ArticleTranslational pediatrics2025

Efficacy of omalizumab in the treatment of STAT3 loss-of-function mutations associated with autosomal dominant hyperimmunoglobulin E syndrome-a case report.

Hongwei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.